Jeffrey A. Graves |
President and CEO, Director |
$4.2M |
+$231K |
+5.82% |
Dec 17, 2024 |
Charles W. Hull |
EVP & Chief Technology Officer, Director |
$1.76M |
-$448K |
-20.3% |
Dec 17, 2024 |
Jagtar Narula |
EVP & Chief Financial Officer |
$1.27M |
|
|
May 20, 2022 |
Jim D. Kever |
Director |
$1.04M |
|
|
Aug 30, 2024 |
Michael Turner |
Former EVP & CFO |
$887K |
|
|
Oct 15, 2023 |
Menno Ellis |
EVP, Healthcare Solutions |
$798K |
|
|
Apr 30, 2024 |
Reji Puthenveetil |
EVP, Additive Solutions & CCO |
$784K |
|
|
Sep 5, 2024 |
Andrew M. Johnson |
EVP, Chief Legal Officer & Sec |
$776K |
|
|
Apr 30, 2024 |
William E. Curran |
Director |
$693K |
|
|
Aug 30, 2024 |
Thomas W. Erickson |
Director |
$686K |
|
|
Aug 30, 2024 |
Jeffrey D. Creech |
Evp & Cfo |
$665K |
|
|
Dec 13, 2024 |
Joseph R. Zuiker |
EVP, Engineering & Operations |
$599K |
|
|
Dec 12, 2024 |
Kevin S. Moore |
Director |
$519K |
|
|
Aug 30, 2024 |
Harriss T. Currie |
President, Regenerative Med |
$466K |
|
|
Dec 16, 2024 |
Phyllis B. Nordstrom |
Evp & Chro |
$455K |
|
|
Dec 2, 2024 |
William D. Humes |
Director |
$333K |
|
|
May 24, 2022 |
Charles G. Mcclure |
Director |
$328K |
|
|
Aug 30, 2024 |
John J. Tracy |
Director |
$325K |
|
|
Aug 30, 2024 |
Jeffrey Wadsworth |
Director |
$276K |
|
|
May 24, 2022 |
Malissia Clinton |
Director |
$269K |
|
|
Aug 30, 2024 |
Vasant Padmanabhan |
Director |
$253K |
|
|
Aug 30, 2024 |
Jeff Blank |
EVP, Engineering and Prod Dev |
$249K |
|
|
Jul 2, 2021 |
Margaret E. Wicklund |
Chief Accounting Officer |
$236K |
|
|
Sep 9, 2024 |
Claudia Drayton |
Director |
$213K |
|
|
Aug 30, 2024 |
Andrew William Banasick Wright |
SVP, GC & Secretary |
$123K |
|
|
Sep 5, 2024 |
David K. Leigh |
EVP & CTO (Additive Mfg) |
$117K |
|
|
Dec 5, 2022 |
Keith Roberson |
VP & Interim General Counsel |
$103K |
|
|
May 1, 2024 |
Anthony Grabenau |
Former PAO |
$85.2K |
|
|
Feb 15, 2021 |
Michael Crimmins |
Former SVP and CAO |
$62.4K |
|
|
Jun 15, 2022 |
Wayne C. Pensky |
Interim CFO |
$47.9K |
|
|
Aug 31, 2022 |